Raymond James & Associates Neogenomics Inc Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Neogenomics Inc stock. As of the latest transaction made, Raymond James & Associates holds 17,520 shares of NEO stock, worth $244,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,520
Holding current value
$244,404
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$13.4 - $17.73 $234,768 - $310,629
17,520 New
17,520 $258,000
Q2 2023

Jul 25, 2023
BUY
$14.1 - $19.83 $157,764 - $221,877
11,189 New
11,189 $179,000
Q3 2022

Oct 25, 2022
SELL
$7.86 - $12.91 $53,275 - $87,503
-6,778 Reduced 25.82%
19,476 $168,000
Q2 2022

Aug 12, 2022
SELL
$7.06 - $13.97 $52,335 - $103,559
-7,413 Reduced 22.02%
26,254 $214,000
Q1 2022

May 11, 2022
SELL
$12.15 - $35.28 $259,135 - $752,451
-21,328 Reduced 38.78%
33,667 $409,000
Q4 2021

Feb 08, 2022
BUY
$30.49 - $48.49 $23,385 - $37,191
767 Added 1.41%
54,995 $1.88 Million
Q3 2021

Nov 02, 2021
SELL
$41.66 - $52.52 $712,385 - $898,092
-17,100 Reduced 23.97%
54,228 $2.62 Million
Q2 2021

Aug 11, 2021
BUY
$36.62 - $51.69 $645,281 - $910,829
17,621 Added 32.81%
71,328 $3.22 Million
Q1 2021

May 14, 2021
SELL
$41.56 - $59.88 $564,883 - $813,888
-13,592 Reduced 20.2%
53,707 $2.59 Million
Q4 2020

Feb 12, 2021
BUY
$36.08 - $56.47 $49,177 - $76,968
1,363 Added 2.07%
67,299 $3.62 Million
Q3 2020

Nov 04, 2020
SELL
$33.26 - $40.48 $81,054 - $98,649
-2,437 Reduced 3.56%
65,936 $2.43 Million
Q2 2020

Jul 28, 2020
SELL
$24.21 - $31.02 $692,236 - $886,954
-28,593 Reduced 29.49%
68,373 $2.12 Million
Q1 2020

Apr 21, 2020
BUY
$20.5 - $34.53 $131,610 - $221,682
6,420 Added 7.09%
96,966 $2.68 Million
Q4 2019

Feb 12, 2020
BUY
$18.96 - $29.84 $426,467 - $671,191
22,493 Added 33.05%
90,546 $2.65 Million
Q3 2019

Nov 07, 2019
BUY
$19.12 - $26.24 $407,963 - $559,882
21,337 Added 45.67%
68,053 $1.3 Million
Q2 2019

Aug 06, 2019
BUY
$19.57 - $24.1 $81,098 - $99,870
4,144 Added 9.73%
46,716 $1.03 Million
Q1 2019

May 06, 2019
BUY
$12.14 - $20.46 $20,832 - $35,109
1,716 Added 4.2%
42,572 $871,000
Q4 2018

Feb 11, 2019
BUY
$11.24 - $18.5 $459,221 - $755,836
40,856 New
40,856 $515,000
Q4 2017

Feb 14, 2018
SELL
$8.02 - $11.18 $84,089 - $117,222
-10,485 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$9.11 - $11.26 $95,518 - $118,061
10,485
10,485 $117,000

Others Institutions Holding NEO

# of Institutions
294
Shares Held
125M
Call Options Held
698K
Put Options Held
116K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.75B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email